This year's Fortune 500 list is out. And pharma companies saw major profit growth
2021 was a year of good fortune for pharmaceutical companies — at least the ones on this year’s Fortune 500 list. Many saw a massive surge in profits last year, led by Gilead and its mammoth 4,961% growth.
However, it appears Gilead isn’t alone in that respect. Despite its gains, the company actually fell 13 spots in Fortune’s rank to No. 129, as several other companies more than doubled their profits.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.